2014
DOI: 10.1186/1471-2407-14-968
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis

Abstract: BackgroundInfection with human papillomavirus (HPV) is necessary for the development of cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies, such as head and neck cancers, is less well characterised. This study aimed to address key information gaps by conducting a systematic review and meta-analysis of the prevalence of HPV infection in head and neck cancers, focusing on data for European populations.MethodsMEDLINE, Embase and grey literature sources were systematically s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
68
0
3

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 82 publications
(77 citation statements)
references
References 61 publications
4
68
0
3
Order By: Relevance
“…In this report, HPV prevalence in OSCC was 26.9%, being markedly higher than that (17.5%) reported in the analysis of Ndiaye et al [31]. HPV prevalence was also higher in Eastern than in Western Europe (34.7 vs. 21.3%) [30]. All HPV type-specific meta-analyses agreed in that the HPV16 genotype is the most prevalent HPV in OSCC, with prevalences of 50–60%, 40%, and 10.7% in the Asian-Pacific region, China, and Europe, respectively [29, 31, 32].…”
Section: Hpv In Hnsccmentioning
confidence: 42%
See 1 more Smart Citation
“…In this report, HPV prevalence in OSCC was 26.9%, being markedly higher than that (17.5%) reported in the analysis of Ndiaye et al [31]. HPV prevalence was also higher in Eastern than in Western Europe (34.7 vs. 21.3%) [30]. All HPV type-specific meta-analyses agreed in that the HPV16 genotype is the most prevalent HPV in OSCC, with prevalences of 50–60%, 40%, and 10.7% in the Asian-Pacific region, China, and Europe, respectively [29, 31, 32].…”
Section: Hpv In Hnsccmentioning
confidence: 42%
“…Only one meta-analysis on HPV prevalence in OSCC covers Europe [30], spanning the period 2002–2012. In this report, HPV prevalence in OSCC was 26.9%, being markedly higher than that (17.5%) reported in the analysis of Ndiaye et al [31].…”
Section: Hpv In Hnsccmentioning
confidence: 99%
“…3 The so-called HPV epidemic is most prominent in patients of Northern European and North American origin, whereas other areas of the world still see few HPVassociated tumors. [4][5][6] In studies that include an assessment of HPV status, a shift in the traditional risk factors is nearly universally noted: viral-associated tumors are seen in younger populations that have lymph node-positive oropharyngeal carcinomas and lower rates of smoking. 7 Having said this, most patients with HPV-associated oropharyngeal carcinoma are still men in their 50s who have a smoking history, and true nonsmokers constitute only a minority.…”
Section: Introductionmentioning
confidence: 99%
“…In our first case, smoking was the biggest risk factor leading to synchronous esophageal squamous and lung adenocarcinoma both of which have been associated with smoking [5]. Tobacco and alcohol consumption can lead to high incidence of tongue and oral mucosal cancer [6]. In some head and neck cancers, HPV infection can be a common trigger leading to multiple primary cancers.…”
Section: Discussionmentioning
confidence: 99%
“…HPV-16 and HPV-18 have been recognized as the culprit in oropharyngeal, laryngeal, tonsillar, anal and cervical cancers. This infection has also been a target for developing anti-cancer vaccination [6]. …”
Section: Discussionmentioning
confidence: 99%